newsfilter
← Latest News
GlobeNewswire·

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights

Interim analysis from the TX45 Phase 1b Part A trial demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with